Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug;12(8):882-9.
doi: 10.1016/j.jalz.2015.12.006. Epub 2016 Jan 23.

Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology

Affiliations

Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology

Erin L Abner et al. Alzheimers Dement. 2016 Aug.

Abstract

Introduction: The relationship of diabetes to specific neuropathologic causes of dementia is incompletely understood.

Methods: We used logistic regression to evaluate the association between diabetes and infarcts, Braak neurofibrillary tangle stage, and neuritic plaque score in 2365 autopsied persons. In a subset of >1300 persons with available cognitive data, we examined the association between diabetes and cognition using Poisson regression.

Results: Diabetes increased odds of brain infarcts (odds ratio [OR] = 1.57, P < .0001), specifically lacunes (OR = 1.71, P < .0001), but not Alzheimer's disease neuropathology. Diabetes plus infarcts was associated with lower cognitive scores at end of life than infarcts or diabetes alone, and diabetes plus high level of Alzheimer's neuropathologic changes was associated with lower mini-mental state examination scores than the pathology alone.

Discussion: This study supports the conclusions that diabetes increases the risk of cerebrovascular but not Alzheimer's disease pathology, and at least some of diabetes' relationship to cognitive impairment may be modified by neuropathology.

Keywords: Alzheimer; Autopsy; Cerebrovascular; Cognition; Diabetes; Infarcts; Neuropathology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Participant inclusion flow diagram a. Honolulu-Asia Aging Study (n=769), the Oregon Brain Aging Study I and II (n=77 and 32), the African American Dementia Project (n=1), the Klamath Exceptional Aging Project (n=80), the Religious Orders Study (n=555), the Memory and Aging Project at Rush University Medical Center (n=454), the Memory and Aging Project at Washington University (n=126), and the Biologically Resilient Adults in Neurological Studies (n=271).

Similar articles

Cited by

References

    1. Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, Sekita A, Suzuki SO, Kanba S, Kiyohara Y, Iwaki T. Insulin resistance is associate with the pathology of Alzheimer disease: the Hiyasama study. Neurology. 2010;75:764–770. - PubMed
    1. Cholerton B, Baker LD, Craft S. Insulin, cognition, and dementia. Eur J Pharmacol. 2013;719:170–179. - PMC - PubMed
    1. Bonfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, Ferreira ST, De Felice FG. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Aβ oligomers. J Clin Invest. 2012;122:1339–1353. - PMC - PubMed
    1. Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, Haneuse S, Craft S, Montine TJ, Kahn SE, McCormick W, McCurry SM, Bowen JD, Larson EB. Glucose levels and risk of dementia. N Eng J Med. 2013;369:540–548. - PMC - PubMed
    1. de la Monte SM, Wands JR. Alzheimer’s disease is Type 3 diabetes—Evidence reviewed. J Diabetes Sci Technol. 2008;3:1101–1113. - PMC - PubMed

Publication types